IHE icon

iShares US Pharmaceuticals ETF

113 hedge funds and large institutions have $118M invested in iShares US Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

18% less capital invested

Capital invested by funds: $143M → $118M (-$25.2M)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
113
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$441K
Puts
$206K
Net Calls
Net Calls Change

Top Buyers

1 +$3.81M
2 +$3.04M
3 +$2.89M
4
Fisher Asset Management
Fisher Asset Management
Washington
+$2.28M
5
UBS Group
UBS Group
Switzerland
+$2.25M

Top Sellers

1 -$6.35M
2 -$5.05M
3 -$3.6M
4
AWS
Atria Wealth Solutions
New York
-$2.95M
5
TRCT
Tower Research Capital (TRC)
New York
-$2.02M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$12.5M
2
$10.3M
3
$10.2M
4
$7.77M
5
$6.64M
6
$6.29M
7
$5.85M
8
$4.62M
9
$3.92M
10
$3.71M
11
$3.12M
12
$3.04M
13
$2.89M
14
$2.57M
15
$2.06M
16
$1.75M
17
$1.65M
18
$1.45M
19
$1.42M
20
$1.2M
21
$1.08M
22
$1.06M
23
$1.03M
24
$1.01M
25
$975K